The following resources have been assembled for early career radiation oncologist reference.

• Contouring/Consensus Guidelines
• Oral Board Study Resources
• ARRO Board Prep

---

Contouring/Consensus Guidelines

Breast

• Whole Breast ASTRO Guideline (2018)
  • https://pubmed.ncbi.nlm.nih.gov/29545124/
• APBI ASTRO Consensus Statement (2017)
  • https://pubmed.ncbi.nlm.nih.gov/27866865/
• Management of Hereditary Breast Cancer, ASCO/ASTRO/SSO Consensus Guideline (2020)
  • https://pubmed.ncbi.nlm.nih.gov/32243226/

Central Nervous System

• Glioblastoma ASTRO Clinical Practice Guideline (2016)
  • https://pubmed.ncbi.nlm.nih.gov/27211230/
• Brain Metastases ASTRO Clinical Practice Guideline (2022)
  • https://pubmed.ncbi.nlm.nih.gov/35534352/
• Postoperative SRS Consensus Contouring Guidelines (2018)
  • https://pubmed.ncbi.nlm.nih.gov/29157748/
• Spine SBRT Consensus Guidelines (2017)
  • https://pubmed.ncbi.nlm.nih.gov/27843035/

Gastrointestinal

• Upper Abdominal OAR RTOG Consensus Contouring Atlas (2014)
  • https://pubmed.ncbi.nlm.nih.gov/24890348/
• Esophagus/GEJ Contouring Consensus Guidelines (2015)
  • https://pubmed.ncbi.nlm.nih.gov/26104943/
• Rectal Cancer ASTRO Clinical Practice Guidelines (2021)
  • https://pubmed.ncbi.nlm.nih.gov/33097436/
• Australasian IMRT Contouring Atlas for Anal Cancer (2012)
  • https://pubmed.ncbi.nlm.nih.gov/22401917/
• Pancreatic Cancer Post-Operative RTOG Consensus Contouring Guideline (2012)
  • https://pubmed.ncbi.nlm.nih.gov/22483737/
• Primary Liver Cancer ASTRO Clinical Practice Guideline (2022)
  • https://pubmed.ncbi.nlm.nih.gov/34688956/

Genitourinary

• Hypofractionated RT for Localized Prostate Cancer ASTRO/ASCO/AUA Guidelines (2019)
  • https://pubmed.ncbi.nlm.nih.gov/30322661/
• ACR Appropriateness Criteria for Locally Advanced, High-Risk Prostate Cancer (2017)
  • https://pubmed.ncbi.nlm.nih.gov/28059930/
• NRG Consensus Atlas for Pelvic Lymph Node Volumes for Prostate Cancer (2021)
  • https://pubmed.ncbi.nlm.nih.gov/32861817/

Gynecological 

• Cervical Cancer Brachytherapy Contouring Consensus Guidelines (2014)
  • https://pubmed.ncbi.nlm.nih.gov/25304792/
• NRG Contouring Consensus Guidelines for Postoperative Treatment of Endometrial and Cervical Cancer (2021)
  • https://pubmed.ncbi.nlm.nih.gov/32905846/
• Endometrial Cancer ASTRO Clinical Practice Guideline (2023)
  • https://pubmed.ncbi.nlm.nih.gov/36280107/
• Vulvar Cancer Contouring Atlas (2016)
  • https://pubmed.ncbi.nlm.nih.gov/27130794/
• GEC-ESTRO-ABS Consensus Brachytherapy Contouring Guidelines for Recurrent Vaginal Endometrial or Cervical Tumors (2023)
  • https://pubmed.ncbi.nlm.nih.gov/36191741/
• Inoperable Endometrial Cancer Brachytherapy Consensus Statement (2015)
  • https://pubmed.ncbi.nlm.nih.gov/26186975/

Head and Neck/Skin

• NRG OAR Contouring Guidelines (2015)
  • https://pubmed.ncbi.nlm.nih.gov/26277855/
• Neck Lymph Node Levels Consensus Guidelines (2013)
  • https://pubmed.ncbi.nlm.nih.gov/24183870/
• Contouring Guidelines for Trigeminal Nerve (2019)
  • https://pubmed.ncbi.nlm.nih.gov/30206021/
• PNI Contouring Guide (2014)
  • https://pubmed.ncbi.nlm.nih.gov/25407876/
• Consensus Guidelines for PORT in Cutaneous SCC (2020)
  • https://pubmed.ncbi.nlm.nih.gov/32289475/
• ASTRO Clinical Practice Guidelines Definitive & Postoperative RT for BCC & SCC of the Skin (2020)
  • https://pubmed.ncbi.nlm.nih.gov/31831330/

Lymphoma

• ILROG Guidelines for Hodgkin Lymphoma (2014)
  • https://www.ncbi.nlm.nih.gov/pubmed/23790512
  • Relapsed/Refractory (2018): https://www.ncbi.nlm.nih.gov/pubmed/29722655
• ILROG Guidelines for Nodal NHL (2014)
  • https://www.ncbi.nlm.nih.gov/pubmed/24725689
• ILROG Guidelines for Extranodal Lymphomas (2015)
  • https://www.ncbi.nlm.nih.gov/pubmed/25863750
• ILROG Guidelines for Relapsed/Refractory DLBCL (2018)
  • https://www.ncbi.nlm.nih.gov/pubmed/?term=29413279
• ILROG Guidelines for Primary Cutaneous Lymphomas (2015)
  • https://www.ncbi.nlm.nih.gov/pubmed/?term=25863751
• ILROG Guidelines for Solitary Plasmacytoma and Multiple Myeloma (2018)
  • https://www.ncbi.nlm.nih.gov/pubmed/?term=29976492
• ILROG ISRT Guidelines (2020)
  • https://pubmed.ncbi.nlm.nih.gov/32272184/

Palliative

• ASTRO Guideline for Palliative RT for Bone Metastases (2017)
  • https://pubmed.ncbi.nlm.nih.gov/27663933/
• Palliative Thoracic RT for NSCLC ASTRO Guideline (2018)
  • https://pubmed.ncbi.nlm.nih.gov/29625898/

Sarcoma

• Soft Tissue Sarcoma ASTRO Clinical Practice Guideline (2021)
  • https://pubmed.ncbi.nlm.nih.gov/34326023/
• Preoperative RT for Retroperitoneal Sarcomas Consensus Guidelines (2015)
  • https://pubmed.ncbi.nlm.nih.gov/26068493/

Thoracic

• Mesothelioma Expert Guidelines (2019)
  • https://pubmed.ncbi.nlm.nih.gov/31125736/
• ARS Appropriate Use Criteria for LS-SCLC (2020)
  • https://pubmed.ncbi.nlm.nih.gov/33166720/
• ARS Appropriate Use Criteria for ES-SCLC (2021)
  • https://pubmed.ncbi.nlm.nih.gov/33011389/
• Definitive RT in Locally Advanced NSCLC, ASTRO Clinical Practice Guideline (2015)
  • https://pubmed.ncbi.nlm.nih.gov/25957184/
• Danish Cardiac Substructure Contouring Atlas (2020)
  • https://pubmed.ncbi.nlm.nih.gov/32544606/
• ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guideline (2023)
  • https://www.practicalradonc.org/article/S1879-8500(23)00111-X/fulltext
• Adjuvant RT in Locally Advanced NSCLC, ASTRO Clinical Practice Guideline (2015)
  • https://pubmed.ncbi.nlm.nih.gov/25957185/

Other

• DEGRO Guidelines for Benign Disorders (2015):
  • Part 1: Principles, Rationale
    • https://pubmed.ncbi.nlm.nih.gov/26117368/
  • Part 2: Painful Degenerative Skeletal Disorders
    • https://pubmed.ncbi.nlm.nih.gov/25238992/
  • Part 3: Hyperproliferative Disorders
    • https://pubmed.ncbi.nlm.nih.gov/25753848/
  • Part 4: Symptomatic Functional Disorders
    • https://pubmed.ncbi.nlm.nih.gov/25487694/
• Precision RT and Molecular Targeting/Immunomodulatory Agents, ASTRO Guideline (2018)
  • https://pubmed.ncbi.nlm.nih.gov/29726389/

 Dose Constraints

• SBRT
  • AAPM TG 101
    • https://doi.org/10.1118/1.3438081
  • “Timmerman Tables”
    • https://pubmed.ncbi.nlm.nih.gov/34919882/

---

Oral Boards Study Resources

**These are a compilation of resources the Early Career Committee members found useful for oral board preparation. ASTRO does not personally endorse any of the below resources.**

 
ABR Certifying Oral Exam Study Guide:

• https://www.theabr.org/radiation-oncology/initial-certification/certifying-exam/studying-for-the-exam/study-guide-oral-exam

Work-Up/Treatment/Staging:

• NCCN Guidelines: https://www.nccn.org/guidelines/category_1

Advice/Boardsmanship:

• Dr. Zaorsky’s Advice: https://twitter.com/NicholasZaorsky/status/1522573006874230785

Courses:

• University of Maryland Mock Orals Course: https://www.medschool.umaryland.edu/radonc/Special-Courses--Events/
• Osler Mock Orals Course: https://www.osler.org/product-category/specialties/radiation-oncology/

Anatomy/Contouring:

• eContour: https://econtour.org/cases
• Zaorsky education threads: https://docs.google.com/document/d/19yXLcKuC-PIexdJdYvn8GMKxoSTZJ-x2UCvhHqwV5Cs/edit
• E-Anatomy (req paid subscription): https://www.imaios.com/en/e-anatomy

 Constraints:

• RadOncReview: https://www.radoncreview.org/constraints
• QUANTEC: http://individual.utoronto.ca/dtsang/misc/quantec.pdf

 Data:

• RadOncReview: https://www.radoncreview.org/
• RadOncTables/Estes Tables: https://docs.google.com/spreadsheets/d/1ydRhk9ZyDr-g0N91q9Ja9Hj1Fvq5y2TwKx-VNG03QFo/edit#gid=2110496431

---

Board Certification Exam Prep

ARRO has created a comprehensive list of study guides and references to assist with prep for radiation oncology board certification. Learn more.

---